Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Industry Award Winner

20 Sep 2007 07:02

BrainJuicer Group PLC20 September 2007 Press Release 20 September 2007 BrainJuicer Group PLC ("BrainJuicer" or "the Company") Winner of Best Methodology at ESOMAR BrainJuicer Group PLC, (AIM: BJU), a leading international online marketresearch agency, today announces that it has been awarded the prize for BestMethodology paper at this year's annual ESOMAR Congress for the Company's newFaceTraceTM product. FaceTraceTM was launched earlier in 2007, and is currently being used by anumber of BrainJuicer's blue chip clients, including Unilever, Shell, Pepsi, andProcter & Gamble. This product offers a new method of measuring emotionalengagement, based on Ekman's research into the way emotions are conveyed andunderstood via the face. Panellists are shown photographs of faces illustratingvarious emotions, and asked to select the one which best represents theirreaction to the product that is being tested. The next stage is to ascertain thedegree to which the emotion is felt, and then explore the reasons behind thereaction. FaceTraceTM is the key tool in the Company's new advertising screeningproduct, as well as being used in collaboration with a number of existingproducts; this further enhances the qualitative depth of research whichBrainJuicer is able to offer its clients. ESOMAR is the global market research association, and its annual Congress thisyear was attended by 1,300 people. There were 170 submissions from all over theworld, 40 selected to be presented at the Congress, and three short listed forprizes in each of the three categories; Best Methodology, Best Case Study andBest Overall Paper. The Best Methodology award is given to the paper of mosttechnical and innovative interest, which adds significant value to the toolsavailable to researchers. BrainJuicer won the Best Methodology Paper prize in 2005 for the Company'sproduct Predictive Markets; this award today makes BrainJuicer the only agencyto win twice in over 20 years. John Kearon, CEO of BrainJuicer, commented: "We are delighted that this new andinnovative product has been recognised by the industry. It validates the strongwork of the team and demonstrates our ability to add value to the researchprocess for our clients. "The fact that we are the only agency to have won this paper twice in over 20years is also a great achievement for the team, as it illustrates howsignificant an impact our products have made on the industry." - Ends - For further information, please contact:BrainJuicer plc John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000 www.brainjuicer.com Landsbanki Securities (UK) LimitedFred Walsh / Simon Brown Tel: +44 (0)20 7426 9000 www.landsbanki.co.uk Media enquiries:Abchurch CommunicationsHeather Salmond / Joanne Shears Tel: +44 (0) 20 7398 7700joanne.shears@abchurch-group.com www.abchurch-group.com Notes to Editors: BrainJuicer carries out quantitative online research using innovative, bespokesoftware to produce insightful market research for large, multinationalcompanies, including 10 of the world's top 50 companies (FT 500 September 2006). BrainJuicer operates in a growing sector of the US$25bn global research market,namely quantitative online research. BrainJuicer's main competitors are largetraditional market research providers who have dominated the market for off-linemarket research, such as AC Nielsen, Millward Brown, Research International andTaylor Nelson Sofres. Whilst the largest traditional research companies have developed their ownonline capability, BrainJuicer has a number of key attributes which havecontributed to it achieving rapid growth and winning contracts with prestigiousclients, including: • Research platform that delivers greater diagnostic insight. BrainJuicer hasdeveloped tools and award-winning techniques that enable it to provide a greaterlevel of diagnostic insight into quantitative market research. These techniquesenable clients to enhance their understanding of consumer preference and helpthem make decisions on the best way to develop their products and services. • Speed. BrainJuicer's automated research techniques enable it to conductcomplicated studies very quickly. BrainJuicer's rapid deployment and resultsproduction, even on multi-country studies, provide clients with a speed tomarket advantage in the development of new products and services. • A scaleable online-only business model. Unlike the traditional researchcompanies who maintain both on and offline data collection capabilities,BrainJuicer is able to focus on operating a scaleable online-only businessmodel. To date the Group has conducted projects in over 50 countries and more than 30languages and has established offices in the UK, the Netherlands and the US. The Group's revenues come from full service market research work, and from itsonline Juicy Brains Panel in the UK. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.